Accolade share price today

(ACCD)

Accolade share price is $3.57 & ₹304.41 as on 27 Dec 2024, 2.30 'hrs' IST

$3.57

▲

0.17

(5%)

Market is closed - opens 8 PM, 27 Dec 2024

View live Accolade share price in Dollar and Rupees. Guide to invest in Accolade from India. Also see the sentimental analysis on Indian investors investing in Accolade. Get details on the Indian mutual funds that are investing in Accolade. Get Analyst recommendations and forecasts along with all the Accolade's financials.

Accolade share price movements

Today's Low: $3.34
Today's High: $3.61
$3.57
6.58%
Downside
Day's Volatility :7.49%
Upside
0.97%
52 Weeks Low: $3.08
52 Weeks High: $15.36
$3.57
13.73%
Downside
52 Weeks Volatility :79.95%
Upside
76.76%

Accolade Returns

Period	Accolade Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-11.92%	-9.0%	0.0%
6 Months	-5.03%	-4.6%	0.0%
1 Year	-73.54%	3.0%	0.0%
3 Years	-86.89%	0.0%	-21.1%

Accolade Key Statistics

in dollars & INR

Previous Close	$3.4
Open	$3.36
Today's High	$3.605
Today's Low	$3.335
Market Capitalization	$273.8M
Today's Volume	$234.2K
52 Week High	$15.36
52 Week Low	$3.08
Revenue TTM	$441.0M
EBITDA	$-53.6M
Earnings Per Share (EPS)	$-1.02
Profit Margin	-18.16%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-18.61%

How to invest in Accolade from India?

It is very easy for Indian residents to invest directly in Accolade from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Accolade stock in both Indian Rupees (INR) and US Dollars (USD). Search for Accolade or ACCD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Accolade or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Accolade shares which would translate to 0.239 fractional shares of Accolade as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Accolade, in just a few clicks!

Returns in Accolade for Indian investors in Rupees

Investment Value

₹1,00,000

Accolade investment value today

Current value as on today

₹30,107

Returns

₹69,893

(-69.89%)

Returns from Accolade Stock

₹72,218 (-72.22%)

Dollar Returns

₹2,325 (+2.33%)

Indian investors sentiment towards Accolade

-19%

Period: Sep 27, 2024 to Dec 26, 2024. Change in 30 Days versus previous period

Search volume for Accolade on INDmoney from India has reduced in the last 30 days as on Dec 27, 2024. -19% less investors are searching Accolade in the last 30 days versus the previous period.

Global Institutional Holdings in Accolade

BlackRock Inc
7.65%
ARK Investment Management LLC
6.68%
Brown Advisory Holdings Inc
5.99%
Vanguard Group Inc
5.16%
Millennium Management LLC
4.95%
Deerfield Management Co
4.31%

Analyst Recommendation on Accolade

Buy

69%Buy

30%Hold

0%Sell

Based on 23 Wall street analysts offering stock ratings for Accolade(by analysts ranked 0 to 5 stars)

Based on 23 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Accolade

What analysts predicted

Upside of 100.96%

Current:

$3.57

Target:

$7.17

Insights on Accolade

Price Movement
In the last 6 months, ACCD stock has moved down by -44.5%
Decreasing Revenue
Revenue is down for the last 3 quarters, 124.83M → 106.36M (in $), with an average decrease of 7.6% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -27.59M → -23.93M (in $), with an average increase of 15.3% per quarter
ACCD vs DOCS (1 yr)
In the last 1 year, Doximity, Inc. has given 106.3% return, outperforming this stock by 178.3%
ACCD vs DOCS (3 yr)
In the last 3 years, Doximity, Inc. has given 13.1% return, outperforming this stock by 100.2%
Price to Sales
ForACCD every $1 of sales, investors are willing to pay $0.6, whereas for Doximity, Inc., the investors are paying $21.0 for every $1 of sales.

Accolade Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$94.8M	↑ 23.41%
Net Income	$-56.5M	↓ 7.82%
Net Profit Margin	-59.59%	↑ 20.18%

	FY20	Y/Y Change
Revenue	$132.5M	↑ 39.76%
Net Income	$-51.4M	↓ 9.08%
Net Profit Margin	-38.76%	↑ 20.83%

	FY21	Y/Y Change
Revenue	$170.4M	↑ 28.57%
Net Income	$-50.7M	↓ 1.39%
Net Profit Margin	-29.73%	↑ 9.03%

	FY22	Y/Y Change
Revenue	$310.0M	↑ 81.98%
Net Income	$-123.1M	↑ 143.08%
Net Profit Margin	-39.71%	↓ 9.98%

	FY23	Y/Y Change
Revenue	$363.1M	↑ 17.13%
Net Income	$-459.7M	↑ 273.32%
Net Profit Margin	-126.58%	↓ 86.87%

	FY24	Y/Y Change
Revenue	$414.3M	↑ 14.09%
Net Income	$-99.8M	↓ 78.29%
Net Profit Margin	-24.09%	↑ 102.49%

	Q2 FY23	Q/Q Change
Revenue	$93.2M	↓ 5.86%
Net Income	$-38.4M	↑ 26.21%
Net Profit Margin	-41.2%	↓ 10.47%

	Q3 FY23	Q/Q Change
Revenue	$96.9M	↑ 3.9%
Net Income	$-32.8M	↓ 14.54%
Net Profit Margin	-33.89%	↑ 7.31%

	Q4 FY23	Q/Q Change
Revenue	$99.4M	↑ 2.59%
Net Income	$-21.1M	↓ 35.83%
Net Profit Margin	-21.2%	↑ 12.69%

	Q1 FY24	Q/Q Change
Revenue	$124.8M	↑ 25.62%
Net Income	$-7.5M	↓ 64.36%
Net Profit Margin	-6.01%	↑ 15.19%

	Q2 FY24	Q/Q Change
Revenue	$110.5M	↓ 11.51%
Net Income	$-27.6M	↑ 267.55%
Net Profit Margin	-24.98%	↓ 18.97%

	Q3 FY24	Q/Q Change
Revenue	$106.4M	↓ 3.72%
Net Income	$-23.9M	↓ 13.26%
Net Profit Margin	-22.5%	↑ 2.48%

	FY19	Y/Y Change
Profit	$34.2M	↑ 46.38%

	FY20	Y/Y Change
Profit	$58.8M	↑ 71.78%

	FY21	Y/Y Change
Profit	$76.7M	↑ 30.37%

	FY22	Y/Y Change
Profit	$141.0M	↑ 83.87%

	FY23	Y/Y Change
Profit	$164.2M	↑ 16.48%

	FY24	Y/Y Change
Profit	$192.1M	↑ 16.94%

	Q2 FY23	Q/Q Change
Profit	$39.0M	↓ 18.66%

	Q3 FY23	Q/Q Change
Profit	$41.5M	↑ 6.47%

	Q4 FY23	Q/Q Change
Profit	$44.9M	↑ 7.96%

	Q1 FY24	Q/Q Change
Profit	$54.3M	↑ 21.12%

	Q2 FY24	Q/Q Change
Profit	$41.5M	↓ 23.68%

	Q3 FY24	Q/Q Change
Profit	$49.4M	↑ 19.23%

	FY19	Y/Y Change
Operating Cash Flow	$-16.5M	↓ 56.78%
Investing Cash Flow	$-3.1M	↓ 56.41%
Financing Cash Flow	$48.8M	↑ 224.71%

	FY20	Y/Y Change
Operating Cash Flow	$-34.2M	↑ 106.96%
Investing Cash Flow	$-3.5M	↑ 12.92%
Financing Cash Flow	$28.2M	↓ 42.21%

	FY21	Y/Y Change
Operating Cash Flow	$-25.2M	↓ 26.32%
Investing Cash Flow	$-2.4M	↓ 31.18%
Financing Cash Flow	$428.4M	↑ 1417.91%

	FY22	Y/Y Change
Operating Cash Flow	$-62.4M	↑ 147.11%
Investing Cash Flow	$-263.6M	↑ 10779.61%
Financing Cash Flow	$257.9M	↓ 39.79%

	FY23	Y/Y Change
Operating Cash Flow	$-40.7M	↓ 34.72%
Investing Cash Flow	$-7.2M	↓ 97.26%
Financing Cash Flow	$3.2M	↓ 98.77%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-19.3M	↑ 653.69%
Investing Cash Flow	$-3.3M	↑ 36.18%
Financing Cash Flow	$4.5M	↑ 964.83%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-8.0M	↓ 58.32%
Investing Cash Flow	$-3.3M	↑ 0.0%
Financing Cash Flow	$641.0K	↓ 85.6%

Accolade Technicals Summary

Sell

Neutral

Buy

Accolade is currently in a neutral trading position according to technical analysis indicators.

Accolade Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Accolade Inc	-9.33%	-5.03%	-73.54%	-86.89%	-88.55%
Solventum Corp	-8.17%	25.87%	-3.68%	-3.68%	-3.68%
Doximity, Inc.	9.14%	108.33%	105.03%	15.14%	9.94%
Veeva Systems Inc.	-4.11%	18.81%	12.07%	-15.86%	54.3%
Ge Healthcare Technologies Inc.	-4.39%	1.85%	2.35%	31.2%	31.2%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Accolade Inc	NA	NA	NA	-1.21	-0.19	-0.07	NA	5.26
Solventum Corp	NA	NA	NA	6.26	0.17	0.08	NA	NA
Doximity, Inc.	66.98	66.98	2.42	0.9	0.19	0.12	NA	5.15
Veeva Systems Inc.	53.82	53.82	1.25	4.76	0.13	0.06	NA	28.8
Ge Healthcare Technologies Inc.	21.74	21.74	8.57	4.28	0.22	0.06	0.0	18.2

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Accolade Inc	Buy	$273.8M	-88.55%	NA	-18.16%
Solventum Corp	Hold	$10.8B	-3.68%	NA	15.73%
Doximity, Inc.	Hold	$10.9B	9.94%	66.98	33.69%
Veeva Systems Inc.	Buy	$35.3B	54.3%	53.82	23.91%
Ge Healthcare Technologies Inc.	Buy	$36.3B	31.2%	21.74	8.56%

About Accolade

accolade is a personalized health and benefits solution that dramatically improves the experience, outcomes and cost of healthcare for employers, health plans and their members. with a unique blend of compassionate advisors, clinical experts and intelligent technologies, we engage individuals and families in their health, establish trust, and influence their decisions at every stage of care. we’ve been recognized as one of the nation’s 25 most promising companies by forbes magazine, the fastest-growing private healthcare company by inc. 500, and a top workplace by multiple news publications. for more information, visit www.accolade.com.

Organization	Accolade
Employees	2400
CEO	Mr. Rajeev Singh
Industry	Health Services

Management People of Accolade

Name	Title
Mr. Rajeev Singh	Chairman of the Board & CEO
Mr. Robert Cavanaugh	President
Mr. Stephen H. Barnes CPA	CFO & Treasurer
Mr. Richard Eskew J.D.	Executive VP, General Counsel, CCO & Secretary
Ms. Kristen Bruzek	Senior Vice President of Operations
Mr. Colin McHugh	Chief Accounting Officer
Mr. Todd Friedman	Senior Vice President of Investor Relations
Ms. Kelsi McDonald Harris	Chief People Officer & Senior Vice President
Mr. Drew Garner	Executive Vice President of Engineering
Dr. Shantanu Nundy M.B.A., M.D.	Executive VP, Chief Health Officer & Member of the Medical Advisory Board

Important FAQs about investing in Accolade from India :

What is Accolade share price today?

Accolade share price today stands at $3.57, Open: $3.36 ; Previous Close: $3.40 ; High: $3.61 ; Low: $3.34 ; 52 Week High: $15.36 ; 52 Week Low: $3.08. The stock opens at $3.36, after a previous close of $3.40. The stock reached a daily high of $3.61 and a low of $3.34, with a 52-week high of $15.36 and a 52-week low of $3.08.

Can Indians buy Accolade shares?

Yes, Indians can invest in the Accolade (ACCD) from India.

With INDmoney, you can buy Accolade at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Accolade at zero transaction cost.

How can I buy Accolade shares from India?

It is very easy to buy Accolade from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Accolade be purchased?

Yes, you can buy fractional shares of Accolade with INDmoney app.

What are the documents required to start investing in Accolade stocks?

To start investing in Accolade, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.